Business Day (Johannesburg)
20 October 2008
Local scientists have started enrolling volunteers in a phase 2 clinical trial to test the safety of a potential tuberculosis (TB) vaccine developed by Dutch pharmaceutical company Crucell and the not-for-profit Aeras Global TB Vaccine Foundation.
[ See Article ]
